Rajeev Sharma, MD
Surgery · Morgantown, WVNPI 1174757652
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,030 of the $4,522 with a category attached, or 89.1%. 14 manufacturers reported payments, led by One Lambda, Inc. at 58.0% of the total. Reporting peaked in 2022 at $2,654 and has fallen 97.1% since, to $77 in 2025.
Across 20 payments — averaging $226.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- One Lambda, Inc.$3K
- Transmedics, Inc.$1K
- Sanofi-aventis U.S. LLC$117
- Veloxis Pharmaceuticals, Inc.$79
- Vanda Pharmaceuticals Inc.$70
- Teva Pharmaceuticals USA, Inc.$35
- plus $190 from 8 others
What the payments were for
- Travel & lodging$4,03089%
- Food & beverage$49211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| One Lambda, Inc. | 1 | $2,623 |
| Transmedics, Inc. | 1 | $1,407 |
| Sanofi-aventis U.S. LLC | 1 | $117 |
| Veloxis Pharmaceuticals, Inc. | 2 | $79 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Mannkind Corporation | 2 | $30 |
| Insulet Corporation | 1 | $28 |
| Tandem Diabetes Care, Inc. | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| AstraZeneca | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Vyera Pharmaceuticals, LLC | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORGAN CARE SYSTEM$1,407
- THYMOGLOBULIN$117
How this compares
$4,522 in reported general payments places this provider in the 70th percentile of 162 surgery providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 12 | $746 |
| Atorvastatin Calcium | 12 | $122 |
| Amlodipine Besylate | 21 | $88 |
| Carvedilol | 17 | $80 |
| Famotidine | 18 | $57 |
| Furosemide | 12 | $37 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $31 |
Paid to pharmacies, not to this prescriber.
Other surgery in Morgantown
- Matthew Cunningham-HillMorgantown$30K
- Maxwell AlmenoffMorgantown$23K
- Todd TallmanMorgantown$15K
- Byron DodsonMorgantown$12K
- Kimberly BaileyMorgantown$7K
- David HofiusMorgantown$5K
- Mustapha DaouadiMorgantown$5K
- Ferdinand MartinezMorgantown$4K
- Darren NeaseCharleston$107K
- Farzad AmiriHuntington$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.